Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes-Reference-Cited by-同舟云学术

Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes

Published:2024-02 Issue: Volume:73 Page:103668
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Dimitrakopoulos Foteinos-Ioannis,Goussia Anna,Koliou Georgia-Angeliki,Dadouli Katerina,Batistatou Anna,Kourea Helen P.,Bobos Mattheos,Arapantoni-Dadioti Petroula,Tzaida Olympia,Koletsa Triantafyllia,Chrisafi Sofia,Sotiropoulou Maria,Papoudou-Bai Alexandra,Nicolaou Irene,Charchanti Antonia,Mauri Davide,Aravantinos Gerasimos,Binas Ioannis,Res Eleni,Psyrri Amanda,Pectasides Dimitrios,Bafaloukos Dimitrios,Koumarianou Anna,Bompolaki Iliada,Rigakos Georgios,Karanikiotis Charisios,Koutras Angelos,Zagouri Flora,Gogas Helen,Fountzilas George

Funder

Hellenic Society of Medical Oncology

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference51 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2022

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

3. European cancer mortality predictions for the year 2019 with focus on breast cancer;Malvezzi;Ann Oncol,2019

4. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Cardoso;Ann Oncol,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclophosphamide/docetaxel/epirubicin;Reactions Weekly;2024-08-31

2. Investigating the Efficacy and Safety of a Dose-Dense Paclitaxel, Cyclophosphamide With Trastuzumab in Stage I-II Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer;Clinical Breast Cancer;2024-07